Leukemia, Myelomonocytic, Chronic
Oncology·MeSH: Leukemia, Myelomonocytic, Chronic
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Leukemia, Myelomonocytic, Chronic?
There are 1 clinical trial targeting Leukemia, Myelomonocytic, Chronic tracked by BioSniper.
What is the prevalence of Leukemia, Myelomonocytic, Chronic?
The estimated prevalence of Leukemia, Myelomonocytic, Chronic is approximately 0.5 per 100,000 population.
Deep-dive into Leukemia, Myelomonocytic, Chronic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis